Rethinking the city and innovation: A political economic view from China's biotech by Zhang, F & Wu, F
Contents lists available at ScienceDirect
Cities
journal homepage: www.elsevier.com/locate/cities
Rethinking the city and innovation: A political economic view from China's
biotech
Fangzhu Zhang, Fulong Wu⁎
Bartlett School of Planning, UCL, Central House, 14 Upper Woburn Place, London WC1H 0NN, UK







A B S T R A C T
The city is arguably where innovations concentrate. Agglomeration and diversity are two major explanations for
why innovations concentrate in the city. Existing studies tend to focus on knowledge dynamics, in particular
interﬁrm networks, while paying insuﬃcient attention to the process of urban development in which knowledge
dynamics are materialized. We concur that the city itself does not possess such a power for innovation
(Shearmur, 2012). Rather, it is an arena where various actors exert impacts on knowledge dynamics. In a view
from China, we reveal why bio-tech innovations concentrate in particular places and what political economic
processes contribute to such concentration. We highlight the need for a political economic analysis in economic
geographical studies of innovation.
1. Introduction
The concentration of economic innovation in the city has almost
‘become a research premise’ as opposed to a research question
(Shearmur, 2012). Numerous publications over the last few years have
been written on the innovative traits of cities (Florida, 2002; Florida,
Adler, & Mellander, 2017; Glaeser, 2011; Krätke, 2014; Simmie, 2001).
The conceptualization of the ‘nature of cities’ as agglomeration (Scott &
Storper, 2015) has triggered a debate largely outside economic geo-
graphy. Given that there is a fruitful literature of relational economic
geography (Bathelt, Malmberg, & Maskell, 2004; Martin & Sunley,
2006; Rutten, 2017; Yeung, 2005), it is therefore the right time to re-
think the connection between innovation and cities (Shearmur, 2012).
However, rather than rehearsing a well-established critique over clus-
ters (e.g. Martin & Sunley, 2003, 2006), we critically review what is
missing in the paradigms of agglomeration and diversity when they are
applied to a diﬀerent context. We tentatively provide a view from
China, in particular biotech innovation.
The objective of this paper is to rethink the relation between the city
and innovation. We try to explain why biotech innovation in China is
heavily concentrated in major cities and particularly their high-tech
parks. Through biotech in Shanghai, we explore how the city becomes
an arena where multiple actors exert their inﬂuence over innovation
capacities. This paper focuses on the connection between innovation
and cities.
The Chinese case provides a good angle to see the concentration of
innovation. As an emerging market in the global South, China has re-
cently experienced economic restructuring and is striving to develop
innovation capacities (Fu, Pietrobelli, & Soete, 2011; Grimes & Du,
2013; Zhang & Wu, 2012). The medium- and long-term science and
technology plan places strategic importance on the new biopharma-
ceutical sector. Combined with the policy of high-tech parks, large ci-
ties are regarded as the main places to realize the sector's innovation
ambitions. Beijing's Zhongguancun, Wuhan's Donghu and Shanghai's
Zhangjiang have been chosen as the ﬁrst three ‘demonstration zones for
indigenous innovation’ (Miao & Hall, 2014; Zhang & Wu, 2012; Zhou,
2008).
Besides the theoretical implications, attention to the role of the city
in innovation is much needed for explaining Chinese innovation. The
current literature on Chinese innovation attributes increasing innova-
tion capacities to state policy (Fu et al., 2011; Prevezer & Tang, 2006;
Su & Hung, 2009; Zhang, Cooke, & Wu, 2011). Studies on bio-
pharmaceutical innovation in East Asian emerging markets pay ex-
tensive attention to the developmental state (Lee, Tee, & Kim, 2009;
Wang, Chen, & Tsai, 2012; Wong, 2011). However, Yeung (2009: 325)
suggests that ‘the developmental state is a necessary but not suﬃcient
condition for regional development to take place’. Scott and Storper
(2015: 12) argue that resort to a peculiar institution may exaggerate the
scope of variations and conceal the ‘intrinsically urban phenomena’.
The paper is organized as follows. In the next section, we review the
literature of two major paradigmatic explanations, agglomeration and
diversity, in innovation. Section 3 proposes the perspective of seeing
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the city as an arena where biotech innovations occur. Section 4 ex-
amines agencies in the development of biotech innovation in Shanghai,
China, to provide an example of our argument. Finally, we conclude
with the importance of political economic analysis within economic
geographic studies of innovation.
2. Agglomeration and diversity and their limitations
The purpose of this section is to review the prevailing paradigms
that explain the emergence of innovations and the limitation of these
explanations. While these two paradigmatic explanations of innovation
help to explain the process in which knowledge and innovation are
created, they are not oriented towards explaining the roles of agents,
market power, and government. They tend to view the city through the
perceived features and impacts on the interaction during knowledge
processes. The intention of this paper is to take a brief step back to look
at the process outside knowledge production, such as urban develop-
ment, planning, and spatial policies, which lead to spatial changes and
hence promote or constrain innovations. This means a political-eco-
nomic view of innovation process is much needed.
The existing paradigms seek to identify the factors that are believed
to be conducive to knowledge generation and innovation.
Agglomeration and diversity are identiﬁed as the major factors. First,
the neo-Marshallian cluster stresses agglomeration. Porter's (1998)
cluster theory emphasizes the eﬀect of self-reinforced agglomeration.
More recently, Scott and Storper (2015) argue that the nature of the city
comes from agglomeration. The original cluster theory focused on the
sameness of ﬁrms and the agglomeration eﬀect associated with the
sameness. The prescription, based on an understanding of agglomera-
tion for regional development, can be seen in ‘new regionalism’, which
has been criticized for its confusion of policy advocacy and underlying
political economy (Lovering, 1999). Cluster theory is criticized for its
excessive attention to spatial proximity (Martin & Sunley, 2003, 2006).
The relational turn of economic geography (Sunley, 2008; Yeung, 2005)
requires more attention to extra-regional connections and an external
environment outside clusters (Phelps, 2004). To overcome the limita-
tion of spatial proximity, Boschma (2005) extends the notion to include
and distinguish diﬀerent types of proximity, for example, cognitive and
institutional proximities.
The concept of the regional innovation system (RIS), however,
emphasizes a wider range of attributes of the environment besides the
available associated ﬁrms. These attributes include, for example, the
institutions and culture of localities (Cooke & Morgan, 1998). RIS ex-
pands not only the geographical scope but also the nature of networks
beyond ﬁrms to include the conditions of a region. For example, social
capital and trust are deemed important features of RIS (Cooke &
Morgan, 1998). Further, local conditions can include the interactive
roles between university, industry and government in the ‘triple helix
model’ (Etzkowitz & Leydesdorﬀ, 2000). The extension of the cluster to
RIS or the triple helix model opens up the possibility of interrogating
the process of urban development, which may include wider concerns
than the cluster. However, conﬁning discussion to concerns over the
region of innovation, they tend to focus more on localities.
Moving away from the territorial view of innovation to a relational
view, greater attention has been paid to the network. The model of
‘local buzz and global pipelines’ proposed by Bathelt et al. (2004)
combines local interactions and translocal linkages. The ‘local buzz’
refers to ‘a complex multilayered information and communication
ecology’ (Bathelt et al., 2004: 45), while these local clusters are con-
nected through pipelines to the rest of the world. The model, however,
is largely concerned with knowledge ﬂows and dynamics. Focusing on
translocal connections, the global production network (GPN) approach
explains how these translocal activities are related to each other. The
perspective of the GPN explains the relation between globalization and
regional changes (Coe, Dicken, & Hess, 2008).
Further, the GPN theory is further enriched by the notion of
‘strategic coupling’ (Coe et al., 2008; MacKinnon, 2012), which em-
phasizes that local ﬁrms are strategically coupled with leading ﬁrms in
the GPN for eﬀective innovation. The perspective has been usefully
applied to understand the development of the liquid crystal display
(LCD) industry in Shenzhen through the coupling of designated do-
mestic ﬁrms and lead ﬁrms in the GPNs (Yang, 2014). A more recent
development is a dynamic view of GPN which may endure decoupling
and recoupling (MacKinnon, 2012). These theories are very close. The
pipeline theory focuses on knowledge linkage while GPN stresses pro-
duction connection.
The relational and evolutionary economic geographies are rich both
in their concepts and in attention to the speciﬁc process of develop-
ment, as Asheim et al. (2011: 899–900) suggest, arguing that ‘it would
be wrong to apply a “one-size-ﬁts-all” policy, such as copying best
practices like Silicon Valley’ and that policies ‘should be based on the
institutional history of a region and which type of intervention ﬁts
better a region's situation, rather than abstract theoretical or ideological
accounts’.
The second major paradigm is the perspective of diversity which
stresses heterogeneity and urban externality as an essential feature of
the urban environment. The chance of unexpected encounters and face-
to-face contact associated with ‘buzz’ enhances innovation (Storper &
Venables, 2004). Combining Jacobs's (1969) insights on diversity and
Joseph Schumpeter's theory of entrepreneurship and innovation,
Florida et al. (2017) explicitly argue for ‘the city as innovation ma-
chine’. Similarly, at the industrial sector and ﬁrm level, Boschma and
Frenken (2006) propose the notion of ‘related variety’, suggesting that
rather than the homogeneity of clustered functions, heterogeneity fa-
cilitates innovation and the creation of new knowledge. Applying ‘re-
latedness’ to knowledge dynamics in biotech at the city level, Boschma,
Heimeriks, and Balland (2014) found that new scientiﬁc topics emerge
in the cities where the related topics already exist. Focusing on
knowledge dynamics and the diﬀerentiation of knowledge bases, a
prescriptive ‘platform policy’ is proposed by Asheim et al. (2011),
which, instead of pursuing clustering, promotes knowledge spill-overs
across sectors. The notion of related variety points to the co-location of
a variety of economic sectors to help cross-fertilize knowledge. For
example, Cooke (2008) emphasizes the Jacobian externality of diversity
in green innovation research and explains that the emergence of clean
technology (as part of green innovation) is due to the co-existence of
diverse ﬁrms from diﬀerent economic sectors, for example, biotech, ICT
and agri-food. Related variety tends to focus on the knowledge dynamic
and pays less attention to the question of how diverse ﬁrms in diﬀerent
sectors come to co-locate in the same locality.
From agglomeration to diversity, although these theories have dif-
ferent emphases, they are largely concerned with the knowledge pro-
cess of innovation. The local-buzz and global-pipeline theory and the
strategic coupling of GPN goes beyond the locality and examine local
and global interactions, paying less attention to the actual and material
processes through which innovation spaces are constructed. All these
approaches highlight the importance of knowledge processes. These
processes are most evident in the city and hence innovation ‘emerge’
from the city. However, the knowledge process cannot ‘play a role’
unlike agents or actors. We aim to show that the city is where a variety
of actors exert their impact on the development and further alter the
processes related to innovation. The process of knowledge exchange is
one of these processes.
3. The city as an arena of innovation
In this section, we propose a perspective in which to think of the
relation between the city and innovation. We consider the city as an
arena of innovation. Multiple actors and agencies assemble during the
course of urban development, which aﬀect innovation. As an arena, the
city is not an actor in itself but a space or ‘assemblage’ which brings
together various actors to pursue their own objectives. These objectives
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may or may not be directly related to innovation or cluster formation.
For example, policies that intervene in the labour market and regulate
land-use planning may have an eﬀect on urban development, which
may further enhance or hamper innovation capacities. Some policies
are directly related to innovation, while others stem more from op-
erational requirements, which may not necessarily bear the aim of in-
novation. While these actors may be dependent upon broad institutions
of development, for example land regulation, and create path-depen-
dent eﬀects, the result can be emergent and path-breaking. For ex-
ample, a pharmaceutical valley has been created in Shanghai, although
the industry has not been a key economic sector of the city in the past.
The development of biotech innovation in Shanghai is thus more stra-
tegic and serves national interests rather than being created by
knowledge dynamics, although without the latter the strategy cannot be
realized.
From the perspective of seeing the city as an arena where multiple
agencies act or exert their agencies, agglomeration is a necessary but
not suﬃcient condition for regional development and innovation. As
seen in Shanghai, agglomeration dynamics are important, because
collaboration within the science park helps to generate knowledge.
However, agglomeration alone cannot fully explain the emergence of
biotech innovation in the park. That is, the emergence of biotech in-
novation in Shanghai could not be simply attributed to cluster and ag-
glomeration dynamics or a diverse knowledge base in Shanghai. Co-
locating in the park may not necessarily lead to collaboration (Prevezer,
2008), although the government strives to foster such dynamics by
setting up a common pool of resources and platforms for sharing
equipment and conducting experiments. The intervention of urban
planning and innovation policies has been critical to the creation of
conditions for innovation, for example developing a new land use and
attracting overseas returnees. The emergence of biotech innovation
hinges upon these conditions being met, particularly in Zhangjiang as a
new suburban place. The growth of Zhangjiang did not start from
earlier agglomeration dynamics. They present a path-breaking trajec-
tory, not because ﬁrms co-locate in the city, but rather because multiple
forces act at the same time to drive the concentration of biotech in-
novation.
Thinking of the city as an arena of development which eventually
aﬀects innovation goes beyond the notion of ‘innovative cities’
(Simmie, 2001), which regards the city as an innovative milieu.
Shanghai has seen the development of multinational research centres,
which is related to but not limited to its global city status. In another
context, it is argued that global cities serve as ‘locational anchoring
points’ for global pharmaceutical and biotech ﬁrms; that is, biotech
ﬁrms are more likely to be associated with or located in global cities
(Krtäke 2014). In many cases the city indeed presents an innovative
environment that is conducive to innovation. The city is what Shearmur
(2012) noted as a ‘key geographical locus’ for innovation, because
‘factors other than interactions and learning factors such as the social
position of agents and their market power’ may also explain why in-
novations are developed in cities (Shearmur, 2012: 515, emphasis
added).
Thinking of the city as an arena also means that the policy of fos-
tering local interaction might not be appropriate in all circumstances, as
Moodysson (2008) ﬁnds in the case of the Swedish Medicon Valley,
where local buzz is largely absent and more meaningful interactions are
along globally conﬁgured professional knowledge communities. Ac-
cording to Shearmur (2012), the city is not necessarily the ‘font of in-
novation’, which means that the political economic forces beyond the
agglomerative and diversity features of the city are acting to produce an
innovation outcome. In many cases, these forces are most forceful and
salient in the city.
There might be some objection that the notion of the arena is quite
similar to the regional innovation system (RIS), a platform or knowl-
edge base (Asheim et al., 2011). How is this understanding diﬀerent
from existing theories such as RIS and platform policies? Understanding
the city as an arena of innovation is not a normative policy prescription.
It does not guarantee that the city is conducive to innovation. There-
fore, a deliberate policy that pursues the territorially concentrated form
of innovation governance does not ensure a positive outcome. The
outcome may not be all positive and contribute to the development of
innovation capacities. For example, the high-tech park policy has long
been recognised as ‘high-tech fantasies’ (Massey, Quintas, & Wield,
1992). The model of ‘Silicon Valley’ has been applied worldwide
(Castells & Hall, 1994; Wong, 2011), but without much success (Miao &
Hall, 2014; Phillips & Yeung, 2003). The notion of the innovation arena
downplays intervention policies that pursue knowledge spill-overs. We
appeal for more critical and context-dependent analysis through
studying the geographies of innovation through comparative govern-
ance studies (Robinson, 2016). This also requires attention to the pro-
cess of development to ask how various agencies are actually as-
sembled. In short, the notion of ‘arena’ is broader than the scope of
innovation components; it is not predeﬁned and not limited to the
factors which are related to innovation. The arena may include oppo-
sition to innovation or speculators who might not be conducive to in-
novation. The understanding of the city as an innovation arena also
diﬀers from thinking that innovation concentrates in the city because of
some trait of the city itself, for example that diversity or richness of
urbanism that can lead to creativity or innovation in general. Peck
(2005) made an extensive critique of associating creativity with mys-
terious ‘creative-city strategies’.
To rethink the connection between cities and innovation, we need to
identify the real actors and their agencies in the city rather than re-
sorting to a general notion of agglomeration, diversity, or relatedness
(between economic sectors). Hence, we need a more political economic
analysis of innovation which has so far been explained extensively
through economic factors. The recent cultural and institutional turn
does signiﬁcantly expand the scope of the new economic geography
beyond economic analysis. But attention to the dynamics of local urban
development and its political economic dynamics is insuﬃcient.
In sum, we argue that the city is an arena where multiple agencies
aﬀect innovation capacities and that the concentration of innovations in
the city is an outcome of the political economic process of the devel-
opment of innovation capacities. The intrinsic dynamics of knowledge
generation, which are extensively studied under agglomeration and
diversity paradigms, underpin the manipulation and politics of devel-
opment, and are necessary but insuﬃcient to understand such a spatial
pattern.
4. A view from China's biotech innovation
In this section, we provide the example of the Zhangjiang High-tech
Park to illustrate the perspective of seeing the city as an arena for
concentrated innovation. The research is based on our previous ex-
tensive empirical studies of the Park since 2008. We have conducted
multiple ﬁeldworks and interviews with biotech ﬁrm CEOs, local
planners in Pudong and in the Shanghai Institute of Planning and
Design, business consultants on park ﬁnance, and biotech lab techni-
cians. We collected extensive documents including a research report by
Shanghai Jiaotong University, government policies related to
Zhangjiang High-tech Park and pharmaceutical industries in Shanghai.
Zhangjiang is a good case to understand the concentration of bio-
tech in high-tech parks in China. It is located in the Pudong new district
of Shanghai. Although it was established in 1992, its development was
slow until 1999 when the Shanghai government developed a policy of
‘Focusing on Zhangjiang’. Still, Zhangjiang is located more in a sub-
urban setting than in an urban environment. The lack of inter-ﬁrm in-
teraction and the lack of an urban atmosphere have been observed. The
park also has a problem of an imbalance between industry and re-
sidential housing.
In the case of Chinese innovation, understanding the post-reform
political economy, especially the multi-scalar governance of the
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Chinese state and its interaction with globalization, helps to explain
why it is the city (rather than a larger subnational region) that has
become the scale for innovation. China oﬀers a remarkable case for
understanding why innovations are concentrated in high-tech parks, as
Chinese cities play an important role in organizing economic develop-
ment through a highly decentralized administrative system. Within the
administrative boundaries of cities, innovation space is clearly deﬁned
into economic and technological development zones (ETDZs) and high-
tech development zones (Cao, 2004), with diﬀerent ranks endorsed by
diﬀerent hierarchies of the state. For example, national high-tech parks
are approved by the central government. These development zones and
industrial parks are substantial operational units, managed by devel-
opment corporations and quasi-government organizations. As a result,
their operation becomes more ‘entrepreneurial’ with a streamlined
governance system.
The current literature on China's innovation rightly pays attention
to the role of the state and its policies in innovation. However, it does
not adequately address how these multiple forces come together in the
city. In this regard, this paper examines the city as an arena where
various forces and agencies interact and co-produce biotech innovation
capacities. This requires some understanding of the entrepreneurial
local state in managing its space (Wu, 2018), for example the high-tech
park (Zhang & Wu, 2012), and in drawing revenue from land to support
infrastructure related to innovation (Zhang, 2015). The local govern-
ment strives to capture mobile resources made available by the central
government and global R&D. In the remainder of this section, we will
analyse the agencies above, within and outside the city.
4.1. The central state: building an innovation nation
The central government has supported Shanghai to become a
Chinese globalizing city. The emergence of biopharmaceuticals has to
be placed within the context of a national strategy to foster ‘indigenous
innovation capacities’. Biopharmaceutical innovation was identiﬁed as
one of eight frontier technologies in the ‘Medium and Long-term
Science and Technology Development Plan’ in 2006 (Zhang et al.,
2011). The role of the central government includes the endorsement of
special status in development zones besides direct resource allocation.
These entitlements help the local government to capture domestic and
international resources. In 2011, Zhangjiang became the third national
demonstration zone for indigenous innovation (Zhang & Wu, 2012).
During the visit of the new Chinese leader, Xi Jinping, to Shanghai in
2014 he stressed that Shanghai should emphasize innovation and sub-
sequently Shanghai announced its ambition to become a ‘global science
and technological innovation centre’. The interaction between the sci-
ence park, the city and the central government can be seen from the
transformation of Zhangjiang from a high-tech development zone to an
innovation centre to implement innovation policies.
Zhangjiang is not just a physical space where biotech companies
cluster, but also an institutional space in which state-allocated re-
sources assemble. In 2006, the State Council renamed ‘Shanghai High-
tech Development Zone’ as ‘Shanghai Zhangjiang High-tech
Development Zone’, which includes Zhangjiang and six other parks in
the metropolitan region. The change could be seen as a branding ex-
ercise as well as a policy to spread and replicate the Zhangjiang in-
novation model (Zhang, 2015). But the assembly of parks expanded
quickly afterwards from 6 parks to 12, 18 and then ﬁnally 22 parks
today in the whole metropolitan area of Shanghai. Without under-
standing the interplay between diﬀerent forces from multi-scalar gov-
ernance, it is diﬃcult to understand the spatial dynamics of innovation.
The perspective allows us to understand the agency above the locality,
in particular the complex role of the state, shifting away from its direct
promotion of science and technological programmes (Wu, 2007; Zhang
et al., 2011) to a more decentralized governance of innovation, which
involves both market mechanisms and state directives in the city.
4.2. The entrepreneurial local government: building innovation spaces
The local government has been incentivised by the tax-sharing
system into an entrepreneurial agent (Wu, 2018) and plays a signiﬁcant
role in building innovation capacities. Speciﬁcally, their agencies in-
clude the following aspects. First, the local government promotes in-
novation through public policies. Following the central government's
directive to build ‘indigenous innovation capacities’, the municipal
government of Shanghai further initiated the policy to ‘Focus on
Zhangjiang’ in 1999, which strengthened the biotech sector in Zhang-
jiang (Zhang & Wu, 2012). Because of this policy initiative, Su and
Hung (2009) argue that Zhangjiang High-tech Park is ‘policy-driven’. A
high-proﬁle management oﬃce is chaired by the mayor of Shanghai.
Second, the local government implements the development of sci-
ence parks through large development corporations. The policy does
not mean that the state now acts like a developmental state taking over
all responsibility for funding and development. But rather the devel-
opment has been driven by a state-owned enterprise. Through the co-
ordination of the management oﬃce, the park development has been
able to break out of divisions between government departments and
bureaucratic constraints. The development of infrastructure resorts to
the land market, which not only develops common park facilities and
experiment platforms but also provides a new source for venture capital
(Zhang, 2015). In post-reform urban governance, the local government
uses development corporations to achieve its development vision. Sci-
ence parks are usually managed by development corporations, for ex-
ample Zhongguancun Science Park in Beijing (Zhou, 2008) and
Zhangjiang high-tech Park (Zhang, 2015; Zhang & Wu, 2012).
Third, the local government fosters links between universities and
industries and inﬂuences universities to either relocate into the high-
tech park or develop joint ventures between universities and industries.
For example, Shanghai municipal government managed to persuade the
Chinese Human Genome Centre to move from Beijing to Zhangjiang
and required the Shanghai Chinese Medical University and its aﬃliated
hospital to relocate from Puxi to Pudong new district. In Zhangjiang
High-tech Park, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,
Ltd. was established in 1996. Fudan University was interested in de-
veloping this branch in Zhangjiang not only because of the access to the
industrial base but also due to the status of Zhangjiang as the ‘National
Indigenous Innovation Zone’ endorsed by the central government.
Fourth, the local government tries to attract talents and skilled
workers through actively participating in the central government pro-
gramme and developing their own talent programmes. In the literature,
tolerant local cultures and rich urbanism are considered important to
attract the ‘creative class’ (Florida, 2002). Consequently, the develop-
ment of social capital through social networks facilitates innovation.
Saxenian (2002) highlights the importance in Taiwan of transnational
immigrants between Hsingchu in Taiwan and Silicon Valley. Similarly,
Chinese returnees play a very important role in building up China's
biotech innovation (Prevezer, 2008). Overseas returnees are not only
scientists but also entrepreneurs who have experience of working in
large Western pharmaceutical companies. The introduction of man-
agerial skills to Chinese enterprises helps to ﬁll a gap in commercia-
lizing technologies. We need to investigate the political economic
process in order to explain talent concentration. The processes go be-
yond agglomeration eﬀect. The talent programmes initiated by the
central government operate on the basis of competition. Universities
and key state-owned enterprises are encouraged to submit strong can-
didates for their positions. Scientists working in private ﬁrms are also
allowed to propose themselves through the high-tech park. For the local
government, the programme is an additional resource from the central
government to boost the local economy, and hence tries to attract
qualiﬁed candidates for competition. As a result, high-tech parks in
large cities such as Shanghai have a better chance of receiving funding
from central and local governments' talent programmes.
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4.3. Global R&D: gaining market access and contract research
Multinationals select large global cities as their bases for R&D
centres because these cities have strong science bases and can provide
market access (Grimes & Miozzo, 2015) and support through contract
research. These cities are able to assemble these diverse resources be-
cause they are global cities and economic centres. Here, we emphasize
the institutional dynamics besides the knowledge dynamics of innova-
tion. Grimes and Miozzo (2015: 1891) studied big pharma's inter-
nationalization of R&D in Shanghai and found that tapping into
knowledge sources outside big pharma's home countries was not the
main driver. Rather, it is a result of greater oﬀshoring activities of early
drug development because China, as a country with a large market, is
becoming an important centre for active pharmaceutical ingredients
(APIs) and clinical trials. Because large pharmas are facing the so-called
‘patent cliﬀ’, which means their existing patents will be ending at si-
milar times, they are competing for the development of generic drugs
(Grimes & Miozzo, 2015: 1890). The use of the Chinese market to de-
velop new drugs is a key reason. For pharmaceutical production, cost
savings and market potential are two major reasons, and the network
formed within the industry is secondary – derived from these devel-
opments at a later stage. Therefore, the relocation and development of
global R&D is more a consideration of ﬁrm strategy rather than of ag-
glomeration in the destination city.
In contrast to Glaeser (2011), who views the local buzz of cities and
the capacities they oﬀer for frequent and unplanned face-to-face con-
tacts, Zeller (2010) identiﬁed the role of global production networks
which created the ‘pharma-biotech complex’ in Boston. Biotech in-
novation seems to be aﬀected by a set of dynamics that may or may not
be necessarily at the scale of the urban (Shearmur, 2012). Important
considerations are cost saving and risk reduction. Here, the city re-
presents a particular governance form, which leads to the promotion of
innovation. Shearmur (2012: S15, also Yeung 2005) argues that ‘cities
appear to be loci of innovation because agents with the social and
market power to promote [innovation…] tend to reside and work in
cities’. As shown here, the high-tech park is located in major cities in
China because the local government has the incentive and power under
decentralized economic governance. The driver of land development
also means the city government has the practical capacity to organize
related infrastructure development to support innovation in high-tech
parks (Zhang, 2015). To multinational pharmaceutical companies,
Shanghai presents a new opportunity as the gateway to the Chinese
market. Within the city, various development zones provide concrete
support for relocating their R&D centres. In short, the external condi-
tions and agencies for biotech innovation may not be created by ag-
glomeration. These agencies, however, regard the city as an important
arena to implement their strategies. Multiple forces across diﬀerent
scales work together to produce the conditions that are attractive to the
concentration of biotech ﬁrms in the city.
4.4. The city as an arena for innovation actors
The city is becoming an arena where all these actors are assembled
to play their roles in biotech innovation. This is not to deny that
knowledge dynamics between ﬁrms are very important. Rather, we
argue that these actors in the arena of the city, in particular in this case
of Zhangjiang, help to develop the conditions for knowledge dynamics.
In the case of Chinese biotech, the central government shifts its gov-
ernance model of innovation from science programmes to high-tech
parks (Wu, 2007). At the same time, the local government is highly
incentivized under ‘state entrepreneurialism’ to pursue economic
growth through urban development (Wu, 2018). Global R&D, facing the
pressure for new drug development, adopts a cost-saving and risk-re-
duction strategy and aims at the vast Chinese market to set up their R&
D centres in major Chinese cities, in particular Shanghai. These actors
have diﬀerent motivations but all happen to exert their inﬂuence on the
development of biotech in Zhangjiang, which leads to a highly con-
centrated pattern of innovation in Shanghai. The rising importance of
innovation and indeed the emergence of new industrial sectors such as
biotech in Chinese cities are also changing the trajectory of urban de-
velopment.
5. Conclusion
This paper attempts to extend the scope of existing economic geo-
graphic studies on the knowledge dynamics of innovation to political
economic analyses of how the knowledge dynamics are materialized,
especially during the process of urban development. The paradigmatic
explanations of agglomeration and diversity are mainly derived from
developed economies in the West. Rather than applying existing the-
ories to the Chinese case, we follow the spirit of comparative urban
studies where new understandings can be generated from ‘elsewhere’
outside the North (Robinson, 2016). Our question is quite intuitively
simple: can these theories help to explain why China's biotech in-
novations emerge and concentrate in major cities such as Shanghai?
This speciﬁc question about the city and innovation requires going
beyond knowledge dynamics, because although knowledge dynamics
are universally observed the intrinsic conditions of knowledge genera-
tion are ‘necessary but not suﬃcient’ (Lovering, 1999) for under-
standing the relation between the city and innovation.
We argue that the city is an arena where various agencies impact
innovation capacities. Together they form variegated institutional dy-
namics of capturing resources and innovation capacities. In China, the
city has become a substantive scale to organize economic development
and provides the state–market interface (Wu, 2018). The ubiquitous
landscape of high-tech parks in Chinese cities has led to the geo-
graphical concentration of innovation. The concentration is not a result
of inter-ﬁrm linkages because ﬁrm-level interactions are still weak
though being strengthened by emerging opportunities (Prevezer, 2008;
Zhang, 2015).
Understanding the city as an arena where multi-scalar forces in-
terweave helps to reveal the development process of innovation. In
China, it is insuﬃcient to attribute the concentration of innovation to
being ‘policy-driven’ or ‘state-led’ or ‘state-sponsored’ (Prevezer & Tang,
2006; Su & Hung, 2009; Zhang et al., 2011), because the Chinese in-
novation system is no longer state-centred and enterprises have become
major actors (Liu & White, 2001). Rather, the state agency plays its role
through concrete geographical space and territorial dynamics. In the
post-reform political economic landscape of China, the city government
becomes a major actor in urban development. While agglomeration and
diversity help to explain knowledge generation, the arrival of big
pharmas in Pudong Pharmaceutical Valley is a response to political
economic conditions created by the urban development process. Clus-
tering is the result of rather than the cause of enhanced innovation
capacities.
Instead of thinking of biotech in Shanghai as an idiosyncratic case,
we should rethink the connection between the city and innovation. The
case shows that the city provides an arena for various actors across
geographical scales. For that purpose, we need to understand the pe-
culiar institutional setting that creates the city as a place for con-
centration, for example in the UK a ‘new regionalism’ in the 1990s was
advocated for upgrading old industrial areas (Lovering, 1999). Phelps
(2008) argues that the concentration of regional innovation is not the
eﬀect of ‘cluster’ but rather the ‘capture’ of local state policies. The
formulations of ‘platform policies’ (Asheim et al., 2011) and ‘triple helix
clusters’ (Etzkowitz & Leydesdorﬀ, 2000) imply more institutional
complexity than has been hinted at as a spatial manifestation of ag-
glomeration. Indeed, the association of innovation with the city may
not be purely driven by knowledge dynamics, as ‘only innovators who
require intense and frequent interactions will pay the cost of locating in
metropolitan areas’ (Shearmur, 2012: s13). More recently there has
been continuing interest in ‘knowledge-based urban development’ and
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‘science cities’ (see Benneworth & Ratinho, 2014, for its practice in the
Netherlands; Forsyth, 2014 for high-tech corridors and other forms).
China's biotech suggests that a more political economic understanding
is needed. Concurring with the appeal from Agnew (2012) for a fuller
understanding of politics in economic geography, we highlight the need
for a political economic analysis in economic geographical studies of
innovation.
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